On Nov. 30 last year, OpenAI released the first free version of ChatGPT. Within 72 hours, doctors were using the artificial intelligence-powered chatbot.
"I was excited and amazed but, to be honest, a little bit alarmed," said Peter Lee, the corporate vice president for research and incubations at Microsoft, which invested in OpenAI.
He and other experts expected that ChatGPT and other A.I.-driven large language models could take over mundane tasks that eat up hours of doctors' time and contribute to burnout, like writing appeals to health insurers or summarizing patient notes.
They worried, though, that artificial intelligence also offered a perhaps too tempting shortcut to finding diagnoses and medical information that may be incorrect or even fabricated, a frightening prospect in a field like medicine.
From The New York Times
View Full Article
No entries found